Selected article for: "disease severity and positive rate"

Author: Yeh, Randy; Elsakka, Ahmed; Wray, Rick; Johnston, Rocio Perez; Gangai, Natalie C.; Yarmohammadi, Hooman; Schoder, Heiko; Pandit-Taskar, Neeta
Title: FDG PET/CT imaging features and clinical utility in COVID-19
  • Cord-id: z6bel4sf
  • Document date: 2021_8_8
  • ID: z6bel4sf
    Snippet: PURPOSE: To determine the imaging findings and potential clinical utility of FDG PET/CT in patients with laboratory-confirmed COVID-19. METHODS: We performed a single institution retrospective review of patients diagnosed with COVID-19 using real time reverse transcription–polymerase chain reaction (RT-PCR) who underwent FDG PET/CT for routine cancer care between March 1, 2020 to April 30, 2020, during the height of the pandemic in New York City, New York, United States. PET/CT scans were retr
    Document: PURPOSE: To determine the imaging findings and potential clinical utility of FDG PET/CT in patients with laboratory-confirmed COVID-19. METHODS: We performed a single institution retrospective review of patients diagnosed with COVID-19 using real time reverse transcription–polymerase chain reaction (RT-PCR) who underwent FDG PET/CT for routine cancer care between March 1, 2020 to April 30, 2020, during the height of the pandemic in New York City, New York, United States. PET/CT scans were retrospectively reviewed for imaging findings suspicious for COVID-19. For positive scans, PET and CT findings were recorded, including location, FDG avidity (SUV(max)) and CT morphology. Patient demographics and COVID-19 specific clinical data were collected and analyzed with respect to PET/CT scan positivity, lung SUV(max), and time interval between PET/CT and RT-PCR. RESULTS: Thirty-one patients (21 males and 10 females, mean age 57 years ± 16) were evaluated. Thirteen of 31 patients had positive PET/CT scans, yielding a detection rate of 41.9%. Patients with positive scans had significantly higher rates of symptomatic COVID-19 infection (77% vs 28%, p = 0.01) and hospitalizations (46% vs. 0%, p = 0.002) compared to patients with negative scans. Eleven of 13 patients (84.6%) with positive scans had FDG-avid lung findings, with mean lung SUV(max) of 5.36. Six of 13 patients (46.2%) had extrapulmonary findings of FDG-avid thoracic lymph nodes. The detection rate was significantly lower when the scan was performed before RT-PCR versus after RT-PCR (18.8% (n = 3/16) vs. 66.7% (n = 10/15), p = 0.009). Lung SUV(max) was not associated with COVID-19 symptoms, severity, or disease course. CONCLUSION: FDG PET/CT has limited sensitivity for detecting COVID-19 infection. However, a positive PET scan is associated with higher risk of symptomatic infection and hospitalizations, which may be helpful in predicting disease severity.

    Search related documents:
    Co phrase search for related documents
    • abnormal finding and lung finding: 1
    • abnormal pet and lung fdg uptake: 1
    • abnormal thoracic and low sensitivity: 1
    • absence presence and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • absence presence and low number: 1, 2, 3
    • absence presence and low sensitivity: 1, 2, 3, 4, 5, 6, 7
    • absence presence and lung finding: 1
    • acute infection and additional diagnosis: 1, 2, 3, 4
    • acute infection and lombardy region: 1, 2, 3, 4
    • acute infection and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute infection and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • acute infection and lung finding: 1, 2, 3, 4, 5
    • additional diagnosis and low sensitivity: 1
    • lombardy region and low number: 1, 2
    • low sensitivity and lung finding: 1